Srikripa Devarakonda Analyst Performance

Biotech Equity Analyst at Truist Financial

Srikripa Devarakonda is a stock analyst at Truist Financial focused in the medical sector, covering 14 publicly traded companies. Over the past year, Srikripa Devarakonda has issued 18 stock ratings, including buy and hold recommendations. While full access to Srikripa Devarakonda's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Srikripa Devarakonda's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 20 Last 4 Years
Buy Recommendations: 80.00% 16 Buy Ratings
Companies Covered: 14 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	80.0%	16 ratings
Hold	20.0%	4 ratings
Sell	0.0%	0 ratings

Out of 20 total stock ratings issued by Srikripa Devarakonda at Truist Financial, the majority (80.0%) have been Buy recommendations, followed by 20.0% Hold.

Best & Worst Calls

Best Call
00.0%
INCY
Oct 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	85.7% of companies on NASDAQ	12 companies
NYSE	14.3% of companies on NYSE	2 companies

Srikripa Devarakonda, an analyst at Truist Financial, currently covers 14 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	92.9%
	Manufacturing 1 company	7.1%

Srikripa Devarakonda of Truist Financial specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 8 companies	57.1%
PHARMACEUTICAL PREPARATIONS 2 companies	14.3%
LARGE CAP PHARMA 2 companies	14.3%
MEDICAL SERVICES 1 company	7.1%
MED - DRUGS 1 company	7.1%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
SRRK Scholar Rock	10/20/2025	Lower Price Target	$28.09	$44.00	Buy
VTRS Viatris	10/15/2025	Initiated Coverage	$9.93	$15.00	Buy
MBX MBX Biosciences	10/15/2025	Initiated Coverage	$13.52	$50.00	Buy
VTRS Viatris	10/15/2025	Initiated Coverage	$9.98	$15.00	Buy
MDGL Madrigal Pharmaceuticals	10/14/2025	Initiated Coverage	$437.10	$580.00	Buy
TERN Terns Pharmaceuticals	10/14/2025	Initiated Coverage	$8.08	$20.00	Buy
KYMR Kymera Therapeutics	9/30/2025	Boost Price Target	$58.33	$68.00	Buy
REGN Regeneron Pharmaceuticals	8/11/2025	Lower Price Target	$559.54	$812.00	Buy
INCY Incyte	7/30/2025	Boost Price Target	$77.98	$79.00	Hold
INCY Incyte	5/27/2025	Boost Price Target	$65.57	$73.00	Hold
ARVN Arvinas	5/5/2025	Reiterated Rating	$7.72	$11.00	Hold
REGN Regeneron Pharmaceuticals	4/30/2025	Lower Price Target	$592.47	$940.00	Buy
BIIB Biogen	4/29/2025	Lower Price Target	$120.86	$199.00	Buy
REGN Regeneron Pharmaceuticals	4/23/2025	Lower Price Target	$589.00	$975.00	Buy
KROS Keros Therapeutics	4/9/2025	Lower Price Target	$9.76	$25.00	Buy
BIIB Biogen	2/13/2025	Lower Price Target	$133.43	$210.00	Buy
LLY Eli Lilly and Company	2/3/2025	Boost Price Target	$814.06	$1,038.00	Buy
ABBV AbbVie	2/3/2025	Boost Price Target	$189.52	$217.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.